These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8857071)
1. Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension. Rangemark C; Lind H; Lindholm L; Hedner T; Samuelsson O Eur J Clin Pharmacol; 1996; 49(4):267-71. PubMed ID: 8857071 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension. Samuelsson O; Hedner T; Ljungman S; Herlitz H; Widgren B; Pennert K Eur J Clin Pharmacol; 1992; 43(5):469-75. PubMed ID: 1336463 [TBL] [Abstract][Full Text] [Related]
3. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791 [TBL] [Abstract][Full Text] [Related]
4. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study. Poulsen PL; Ebbehøj E; Mogensen CE J Intern Med; 2001 May; 249(5):433-40. PubMed ID: 11350567 [TBL] [Abstract][Full Text] [Related]
5. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654 [TBL] [Abstract][Full Text] [Related]
7. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH Diabetes; 1994 Sep; 43(9):1108-13. PubMed ID: 8070610 [TBL] [Abstract][Full Text] [Related]
8. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients. Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500 [TBL] [Abstract][Full Text] [Related]
9. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS. Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701 [TBL] [Abstract][Full Text] [Related]
10. A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril. Antonios TF; Cappuccio FP; Markandu ND; Sagnella GA; MacGregor GA Hypertension; 1996 Jun; 27(6):1325-8. PubMed ID: 8641743 [TBL] [Abstract][Full Text] [Related]
12. Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function. Poulsen PL; Ebbehøj E; Nosadini R; Fioretto P; Deferrari G; Crepaldi G; Mogensen CE Diabetes Metab; 2001 Apr; 27(2 Pt 1):123-8. PubMed ID: 11353877 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension]. Widecka K; Celibała R; Czekalski S Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231 [TBL] [Abstract][Full Text] [Related]
14. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects. Patel V; Rassam SM; Chen HC; Jones M; Kohner EM Metabolism; 1998 Dec; 47(12 Suppl 1):28-33. PubMed ID: 9867068 [TBL] [Abstract][Full Text] [Related]
16. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106 [TBL] [Abstract][Full Text] [Related]
17. A study of the effects of lisinopril when used in addition to atenolol. Soininen K; Gerlin-Piira L; Suihkonen J; Kyllönen T; Parviainen R; Kyllönen E; Hämäläinen K; Lonka R; Tikkanen T; Selonen R J Hum Hypertens; 1992 Aug; 6(4):321-4. PubMed ID: 1331443 [TBL] [Abstract][Full Text] [Related]
18. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study. Rossing K; Christensen PK; Jensen BR; Parving HH Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908 [TBL] [Abstract][Full Text] [Related]
19. Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade. Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A Am J Hypertens; 1996 Sep; 9(9):850-3. PubMed ID: 8879340 [TBL] [Abstract][Full Text] [Related]
20. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis. Georgianos PI; Agarwal R Clin J Am Soc Nephrol; 2015 Apr; 10(4):639-45. PubMed ID: 25784174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]